ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic HIV Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2K14613
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Therapeutic HIV Vaccine Market Research Report 2023
BUY CHAPTERS

Global Therapeutic HIV Vaccine Market Research Report 2025

Code: QYRE-Auto-2K14613
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mylan NV
AbbVie
Merck& Co. Inc
Bristol Myers Squibb Company
Boehringer Ingelheim GmbH
Genentech Inc
Cipla Ltd
ViiV Healthcare

Therapeutic HIV Vaccine Market

The global market for Therapeutic HIV Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A therapeutic HIV vaccine is a vaccine that is designed to improve the body"s immune response to HIV in a person who already has HIV.
According to the United Nations AIDS Program (UNAIDS), 38.4 million people are currently infected with HIV worldwide, and 1.5 million people will be newly infected in 2021. HIV has always been a difficult problem facing the world. After years of research and trials, except for a very few cases of bone marrow transplantation, there is currently no cure for this infection. It can only be controlled indefinitely with antiviral drugs. Prevents it from developing into the fatal immunodeficiency syndrome (AIDS). The main reason for the difficulty in developing an AIDS vaccine is the genetic diversity and mutation ability of the HIV virus, which enables it to effectively escape the human immune system. In addition, the conformation of the antigenic protein Env on the surface of the HIV virus is very unstable before fusion, which is a difficult problem that scientists have faced for many years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic HIV Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic HIV Vaccine.
The Therapeutic HIV Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic HIV Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic HIV Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Therapeutic HIV Vaccine Market Report

Report Metric Details
Report Name Therapeutic HIV Vaccine Market
Segment by Type
  • NRTIs
  • NNRTIs
  • Entry and Fusion Inhibitors
  • Protease Inhibitors
  • Integrase Inhibitors
  • Coreceptor Antagonists
Segment by Application
  • Hospitals
  • Clinics
  • Labs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Therapeutic HIV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Therapeutic HIV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Therapeutic HIV Vaccine Market report?

Ans: The main players in the Therapeutic HIV Vaccine Market are ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc.

What are the Application segmentation covered in the Therapeutic HIV Vaccine Market report?

Ans: The Applications covered in the Therapeutic HIV Vaccine Market report are Hospitals, Clinics, Labs

What are the Type segmentation covered in the Therapeutic HIV Vaccine Market report?

Ans: The Types covered in the Therapeutic HIV Vaccine Market report are NRTIs, NNRTIs, Entry and Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors, Coreceptor Antagonists

1 Therapeutic HIV Vaccine Market Overview
1.1 Product Definition
1.2 Therapeutic HIV Vaccine by Type
1.2.1 Global Therapeutic HIV Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 NRTIs
1.2.3 NNRTIs
1.2.4 Entry and Fusion Inhibitors
1.2.5 Protease Inhibitors
1.2.6 Integrase Inhibitors
1.2.7 Coreceptor Antagonists
1.3 Therapeutic HIV Vaccine by Application
1.3.1 Global Therapeutic HIV Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Global Therapeutic HIV Vaccine Market Size Estimates and Forecasts
1.4.1 Global Therapeutic HIV Vaccine Revenue 2020-2031
1.4.2 Global Therapeutic HIV Vaccine Sales 2020-2031
1.4.3 Global Therapeutic HIV Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Therapeutic HIV Vaccine Market Competition by Manufacturers
2.1 Global Therapeutic HIV Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Therapeutic HIV Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Therapeutic HIV Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Therapeutic HIV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic HIV Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic HIV Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Therapeutic HIV Vaccine, Date of Enter into This Industry
2.8 Global Therapeutic HIV Vaccine Market Competitive Situation and Trends
2.8.1 Global Therapeutic HIV Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Therapeutic HIV Vaccine Players Market Share by Revenue
2.8.3 Global Therapeutic HIV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Therapeutic HIV Vaccine Market Scenario by Region
3.1 Global Therapeutic HIV Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Therapeutic HIV Vaccine Sales by Region: 2020-2031
3.2.1 Global Therapeutic HIV Vaccine Sales by Region: 2020-2025
3.2.2 Global Therapeutic HIV Vaccine Sales by Region: 2026-2031
3.3 Global Therapeutic HIV Vaccine Revenue by Region: 2020-2031
3.3.1 Global Therapeutic HIV Vaccine Revenue by Region: 2020-2025
3.3.2 Global Therapeutic HIV Vaccine Revenue by Region: 2026-2031
3.4 North America Therapeutic HIV Vaccine Market Facts & Figures by Country
3.4.1 North America Therapeutic HIV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Therapeutic HIV Vaccine Sales by Country (2020-2031)
3.4.3 North America Therapeutic HIV Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Therapeutic HIV Vaccine Market Facts & Figures by Country
3.5.1 Europe Therapeutic HIV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Therapeutic HIV Vaccine Sales by Country (2020-2031)
3.5.3 Europe Therapeutic HIV Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic HIV Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Therapeutic HIV Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Therapeutic HIV Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Therapeutic HIV Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Therapeutic HIV Vaccine Market Facts & Figures by Country
3.7.1 Latin America Therapeutic HIV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Therapeutic HIV Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Therapeutic HIV Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic HIV Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic HIV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Therapeutic HIV Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Therapeutic HIV Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic HIV Vaccine Sales by Type (2020-2031)
4.1.1 Global Therapeutic HIV Vaccine Sales by Type (2020-2025)
4.1.2 Global Therapeutic HIV Vaccine Sales by Type (2026-2031)
4.1.3 Global Therapeutic HIV Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Therapeutic HIV Vaccine Revenue by Type (2020-2031)
4.2.1 Global Therapeutic HIV Vaccine Revenue by Type (2020-2025)
4.2.2 Global Therapeutic HIV Vaccine Revenue by Type (2026-2031)
4.2.3 Global Therapeutic HIV Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Therapeutic HIV Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Therapeutic HIV Vaccine Sales by Application (2020-2031)
5.1.1 Global Therapeutic HIV Vaccine Sales by Application (2020-2025)
5.1.2 Global Therapeutic HIV Vaccine Sales by Application (2026-2031)
5.1.3 Global Therapeutic HIV Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Therapeutic HIV Vaccine Revenue by Application (2020-2031)
5.2.1 Global Therapeutic HIV Vaccine Revenue by Application (2020-2025)
5.2.2 Global Therapeutic HIV Vaccine Revenue by Application (2026-2031)
5.2.3 Global Therapeutic HIV Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Therapeutic HIV Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ViiV Healthcare
6.1.1 ViiV Healthcare Company Information
6.1.2 ViiV Healthcare Description and Business Overview
6.1.3 ViiV Healthcare Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ViiV Healthcare Therapeutic HIV Vaccine Product Portfolio
6.1.5 ViiV Healthcare Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Therapeutic HIV Vaccine Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AbbVie Therapeutic HIV Vaccine Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Merck & Co., Inc.
6.4.1 Merck & Co., Inc. Company Information
6.4.2 Merck & Co., Inc. Description and Business Overview
6.4.3 Merck & Co., Inc. Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck & Co., Inc. Therapeutic HIV Vaccine Product Portfolio
6.4.5 Merck & Co., Inc. Recent Developments/Updates
6.5 Bristol-Myers Squibb Company
6.5.1 Bristol-Myers Squibb Company Company Information
6.5.2 Bristol-Myers Squibb Company Description and Business Overview
6.5.3 Bristol-Myers Squibb Company Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bristol-Myers Squibb Company Therapeutic HIV Vaccine Product Portfolio
6.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6 Boehringer Ingelheim GmbH
6.6.1 Boehringer Ingelheim GmbH Company Information
6.6.2 Boehringer Ingelheim GmbH Description and Business Overview
6.6.3 Boehringer Ingelheim GmbH Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Ingelheim GmbH Therapeutic HIV Vaccine Product Portfolio
6.6.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.7 Genentech, Inc.
6.7.1 Genentech, Inc. Company Information
6.7.2 Genentech, Inc. Description and Business Overview
6.7.3 Genentech, Inc. Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Genentech, Inc. Therapeutic HIV Vaccine Product Portfolio
6.7.5 Genentech, Inc. Recent Developments/Updates
6.8 Cipla, Inc.
6.8.1 Cipla, Inc. Company Information
6.8.2 Cipla, Inc. Description and Business Overview
6.8.3 Cipla, Inc. Therapeutic HIV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cipla, Inc. Therapeutic HIV Vaccine Product Portfolio
6.8.5 Cipla, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic HIV Vaccine Industry Chain Analysis
7.2 Therapeutic HIV Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic HIV Vaccine Production Mode & Process Analysis
7.4 Therapeutic HIV Vaccine Sales and Marketing
7.4.1 Therapeutic HIV Vaccine Sales Channels
7.4.2 Therapeutic HIV Vaccine Distributors
7.5 Therapeutic HIV Vaccine Customer Analysis
8 Therapeutic HIV Vaccine Market Dynamics
8.1 Therapeutic HIV Vaccine Industry Trends
8.2 Therapeutic HIV Vaccine Market Drivers
8.3 Therapeutic HIV Vaccine Market Challenges
8.4 Therapeutic HIV Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Mylan NV
AbbVie
Merck& Co. Inc
Bristol Myers Squibb Company
Boehringer Ingelheim GmbH
Genentech Inc
Cipla Ltd
ViiV Healthcare
List of Tables
 Table 1. Global Therapeutic HIV Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Therapeutic HIV Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Therapeutic HIV Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Therapeutic HIV Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Therapeutic HIV Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Therapeutic HIV Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Therapeutic HIV Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Therapeutic HIV Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Therapeutic HIV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Therapeutic HIV Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Therapeutic HIV Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Therapeutic HIV Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Therapeutic HIV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic HIV Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Therapeutic HIV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Therapeutic HIV Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Therapeutic HIV Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Therapeutic HIV Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Therapeutic HIV Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Therapeutic HIV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Therapeutic HIV Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Therapeutic HIV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Therapeutic HIV Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Therapeutic HIV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Therapeutic HIV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Therapeutic HIV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Therapeutic HIV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Therapeutic HIV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Therapeutic HIV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Therapeutic HIV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Therapeutic HIV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Therapeutic HIV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Therapeutic HIV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Therapeutic HIV Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Therapeutic HIV Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Therapeutic HIV Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Therapeutic HIV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Therapeutic HIV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Therapeutic HIV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Therapeutic HIV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Therapeutic HIV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Therapeutic HIV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Therapeutic HIV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Therapeutic HIV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Therapeutic HIV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Therapeutic HIV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Therapeutic HIV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Therapeutic HIV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Therapeutic HIV Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Therapeutic HIV Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Therapeutic HIV Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Therapeutic HIV Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Therapeutic HIV Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Therapeutic HIV Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Therapeutic HIV Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Therapeutic HIV Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Therapeutic HIV Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Therapeutic HIV Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Therapeutic HIV Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Therapeutic HIV Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Therapeutic HIV Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Therapeutic HIV Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Therapeutic HIV Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Therapeutic HIV Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Therapeutic HIV Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Therapeutic HIV Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Therapeutic HIV Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Therapeutic HIV Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. ViiV Healthcare Company Information
 Table 71. ViiV Healthcare Description and Business Overview
 Table 72. ViiV Healthcare Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. ViiV Healthcare Therapeutic HIV Vaccine Product
 Table 74. ViiV Healthcare Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan Therapeutic HIV Vaccine Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. AbbVie Company Information
 Table 81. AbbVie Description and Business Overview
 Table 82. AbbVie Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AbbVie Therapeutic HIV Vaccine Product
 Table 84. AbbVie Recent Developments/Updates
 Table 85. Merck & Co., Inc. Company Information
 Table 86. Merck & Co., Inc. Description and Business Overview
 Table 87. Merck & Co., Inc. Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck & Co., Inc. Therapeutic HIV Vaccine Product
 Table 89. Merck & Co., Inc. Recent Developments/Updates
 Table 90. Bristol-Myers Squibb Company Company Information
 Table 91. Bristol-Myers Squibb Company Description and Business Overview
 Table 92. Bristol-Myers Squibb Company Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bristol-Myers Squibb Company Therapeutic HIV Vaccine Product
 Table 94. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 95. Boehringer Ingelheim GmbH Company Information
 Table 96. Boehringer Ingelheim GmbH Description and Business Overview
 Table 97. Boehringer Ingelheim GmbH Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Boehringer Ingelheim GmbH Therapeutic HIV Vaccine Product
 Table 99. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 100. Genentech, Inc. Company Information
 Table 101. Genentech, Inc. Description and Business Overview
 Table 102. Genentech, Inc. Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Genentech, Inc. Therapeutic HIV Vaccine Product
 Table 104. Genentech, Inc. Recent Developments/Updates
 Table 105. Cipla, Inc. Company Information
 Table 106. Cipla, Inc. Description and Business Overview
 Table 107. Cipla, Inc. Therapeutic HIV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Cipla, Inc. Therapeutic HIV Vaccine Product
 Table 109. Cipla, Inc. Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Therapeutic HIV Vaccine Distributors List
 Table 113. Therapeutic HIV Vaccine Customers List
 Table 114. Therapeutic HIV Vaccine Market Trends
 Table 115. Therapeutic HIV Vaccine Market Drivers
 Table 116. Therapeutic HIV Vaccine Market Challenges
 Table 117. Therapeutic HIV Vaccine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Therapeutic HIV Vaccine
 Figure 2. Global Therapeutic HIV Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Therapeutic HIV Vaccine Market Share by Type: 2024 & 2031
 Figure 4. NRTIs Product Picture
 Figure 5. NNRTIs Product Picture
 Figure 6. Entry and Fusion Inhibitors Product Picture
 Figure 7. Protease Inhibitors Product Picture
 Figure 8. Integrase Inhibitors Product Picture
 Figure 9. Coreceptor Antagonists Product Picture
 Figure 10. Global Therapeutic HIV Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Therapeutic HIV Vaccine Market Share by Application: 2024 & 2031
 Figure 12. Hospitals
 Figure 13. Clinics
 Figure 14. Labs
 Figure 15. Global Therapeutic HIV Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Therapeutic HIV Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Therapeutic HIV Vaccine Sales (2020-2031) & (K Units)
 Figure 18. Global Therapeutic HIV Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 19. Therapeutic HIV Vaccine Report Years Considered
 Figure 20. Therapeutic HIV Vaccine Sales Share by Manufacturers in 2024
 Figure 21. Global Therapeutic HIV Vaccine Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Therapeutic HIV Vaccine Players: Market Share by Revenue in Therapeutic HIV Vaccine in 2024
 Figure 23. Therapeutic HIV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Therapeutic HIV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Therapeutic HIV Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. North America Therapeutic HIV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. United States Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Therapeutic HIV Vaccine Sales Market Share by Country (2020-2031)
 Figure 30. Europe Therapeutic HIV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Therapeutic HIV Vaccine Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Therapeutic HIV Vaccine Revenue Market Share by Region (2020-2031)
 Figure 38. China Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Therapeutic HIV Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Therapeutic HIV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Therapeutic HIV Vaccine Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Therapeutic HIV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Therapeutic HIV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Therapeutic HIV Vaccine by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Therapeutic HIV Vaccine by Type (2020-2031)
 Figure 59. Global Therapeutic HIV Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Therapeutic HIV Vaccine by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Therapeutic HIV Vaccine by Application (2020-2031)
 Figure 62. Global Therapeutic HIV Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 63. Therapeutic HIV Vaccine Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global HIV Vaccine Market Research Report 2025
Global HIV and AIDS Vaccine Market Research Report 2024
Global HIV Therapy Market Research Report 2025
Global Travelers Vaccination Market Research Report 2025
Global Travelers Vaccines Market Research Report 2025
Global Therapeutic Cancer Vaccines Market Research Report 2024
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Veterinary Biological Vaccines Market Research Report 2025
Global Viral Vector Vaccine for Humans Market Research Report 2024
Global Human Vaccination Market Research Report 2025
Global Veterinary Vaccination Market Research Report 2025
Veterinary Vaccine Market
Global Livestock Animal Vaccines Market Research Report 2024
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Clinical Trials Market Research Report 2025
Global Human Immunodeficiency Virus Testing Market Research Report 2024
Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV and AIDS Clinical Trials Market Research Report 2025
Global HIV Therapy Drug Market Research Report 2025
Global Livestock Animal Vaccination Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions